调肝理肺法治疗慢性阻塞性肺疾病稳定期的临床应用  

Clinical application of liver toning and lung regulating method in the treatment of chronic obstructive pulmonary disease in the stable stage

作　　者：徐雨辰 张立山[2] 王金娥 王婧 任传云[2] 武维屏(指导)[2] XU Yuchen;ZHANG Lishan;WANG Jin'e;WANG Jing;REN Chuanyun;WU Weiping(The First Clinical Medical College,Bejing University of Chinese Medicine,Beijing 100029,China;Dongzhimen Hospital,Beijing University of Chinese Medicine,Beijing 100700,China)

机构地区：[1]北京中医药大学第一临床医学院,北京100029 [2]北京中医药大学东直门医院,北京100700

出　　处：《中华中医药杂志》2025年第3期1234-1236,共3页China Journal of Traditional Chinese Medicine and Pharmacy

基　　金：第七批全国老中医药专家学术经验继承工作项目(No.国中医药人教函【2021】272号);北京市东城区优秀人才培养项目(No.东人才办发【2014】5号)。

摘　　要：武维屏教授根据临床诊治慢性阻塞性肺疾病(COPD)稳定期的经验及现代研究,提出COPD稳定期患者具有“虚、痰、瘀”的病机特点,对应补虚、化痰、行瘀以理肺平喘的治则治法;根据武教授临床治疗COPD稳定期的处方用药规律,清半夏、柴胡、黄芩使用频率最高,常配合补虚、清热、解表、化痰止咳平喘等药物,核心处方以小柴胡汤合半夏厚朴汤、小青龙汤等方加减为多,通过调肝理肺法将补虚、化痰、行瘀、理肺治则相串联,从脏腑相关的角度改善肺的气血运行,杜绝痰瘀之源,为临床提供治疗思路。Based on clinical experience and modern research,professor wU Weiping proposed that patients with chronic obstructive pulmonary disease(COPD)in the stable stage have the characteristics of‘deficiency,phlegm and stasis',and the treatment method should be to tonify deficiency,resolve phlegm and eliminate stasis in order to regulate the lung and calm asthma.According to professor WU's prescription pattern in the clinical treatment of COPD in the stable stage,Huangqin are used most frequently,often together with drugs to tonify deficiency,clear heat,relieve symptoms,resolve phlegm,relieve cough and asthma,et..The core prescriptions are Xiao Chaihu Decoction combined with Banxia Houpu Decoction and Xiao Qinglong Decoction,which provide clinical treatment ideas by regulating the liver and lung,linking the treatment rules of tonifying deficiency,resolving phlegm,removing blood stasis and regulating the lung,improving the flow of qi and blood in the lung from the perspective of the internal organs,and eliminating the source of phlegm and blood stasis.

关 键 词：武维屏 慢性阻塞性肺疾病 调肝理肺 小柴胡汤 脏腑 

分 类 号：R563.9[医药卫生—呼吸系统] R256.1[医药卫生—内科学]